Aniling at ESHG 2026 | Illumina Corporate Session
We are pleased to announce that Aniling will be presenting at the European Human Genetics Conference (ESHG) 2026 in Gothenburg, Sweden, as part of the Illumina corporate session. Our colleague …
Strategic Collaboration using Illumina sequencing platforms to advance Unified Genomic and Epigenetic Assays in Oncology
Aniling has entered into a strategic collaboration with Illumina where Aniling will integrate its GEUS technology with Illumina sequencing platforms. The collaboration will enable Aniling to access Illumina sequencing platforms to advance its unified genomic and epigenetic …
GEUS-COMPASS: Shaping the Future of Early Cancer Detection
GEUS-COMPASS is a €2.2 million project that brings together cutting-edge genomics, epigenomics, and artificial intelligence to transform how we detect cancer before symptoms appear. Funded by the Spanish Ministry of …
Aniling announces IGTP as a GEUS Certified Service Provider
Aniling is pleased to announce certification of the High Content Genomics and Bioinformatics Platform at Germans Trias i Pujol Research Institute (IGTP) as a GEUS Certified Service Provider. The Genome …
GEUS-CRC: Transforming Colorectal Cancer Care through Integrated Genetic and Epigenetic Profiling
GEUS-CRC is based on Aniling’s GEUS (Genetic and Epigenetic Unified Sequencing) technology optimized specifically for colorectal cancer. This unique platform enables simultaneous analysis of genetic and epigenetic alterations from a …
Introducing the Next Generation of GEUS-CLL, the Most Comprehensive Diagnostic Kit for Chronic Lymphocytic Leukemia
– Reaching True Color Diagnostics in CLL – Aniling is proud to unveil the next generation of our GEUS-CLL, an advanced evolution of its molecular diagnostic kit for Chronic Lymphocytic …
AI, Genomics, and Epigenomics: Transforming Precision Medicine
At Aniling, we recognize the transformative potential of AI in precision medicine, especially when combined with the power of genetic and epigenetic data. As part of a project funded by …
Aniling is celebrating the successful inspection carried out by the AEMPS
In July, Aniling successfully passed a crucial inspection conducted by the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), reaffirming its commitment to quality and compliance in the manufacturing of …
Aniling Renews ISO 13485:2016 Certification
Aniling, a biotechnology company specialized in diagnostics using a unique and proprietary technology analyzing both genomic and epigenomic biomarkers, is proud to announce the successful renewal of its ISO 13485:2016 certification, …
Aniling obtains European certification for diagnostic tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy
Aniling has obtained CE certification for its first in vitro diagnostic (IVD) tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy. Aniling has successfully complied with the requirements established …